株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

バイオフォトニクスの世界市場予測

Global Biophotonics Market Forecast 2019-2027

発行 Inkwood Research 商品コード 530648
出版日 ページ情報 英文 150 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.28円で換算しております。
Back to Top
バイオフォトニクスの世界市場予測 Global Biophotonics Market Forecast 2019-2027
出版日: 2019年01月20日 ページ情報: 英文 150 Pages
概要

当レポートでは、バイオフォトニクスの世界市場について調査し、技術・エンドユーザー・用途・地域別の市場動向、市場規模の推移と予測、市場成長への各種影響要因、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 促進要因
  • 阻害要因
  • 機会
  • 課題

第5章 市場区分

  • 技術別
    • インビトロ
    • インビボ
  • エンドユーザー別
    • 治療
    • 診断
    • テストコンポーネント
    • 医療以外
  • 用途別
    • 内視鏡
    • 透過画像
    • スペクトル分子画像
    • 顕微鏡
    • 表面イメージング
    • 光療法
    • バイオセンサー
    • その他

第6章 市場分析

  • ファイブフォース分析
  • 購買基準
  • 戦略的提言
  • 市場機会のマトリクス
  • ベンダー概要

第7章 地域区分

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 企業プロファイル

  • 競合情勢
    • 市場シェアの分析
    • 優れた事業戦略
  • ADVANDX INC.( ACQUIRED BY OPGEN)
  • BECTON, DICKINSON, AND COMPANY
  • CARL ZEISS AG
  • FISBA AG
  • HALMA PLC
  • 浜松ホトニクス
  • IDEX CORP.
  • LUMENIS LTD.
  • MEDLUMICS SL
  • NEWPORT CORPORATION (ACQUIRED BY MKS INSTRUMENT)
  • オリンパス
  • OXFORD INSTRUMENTS
  • PERKINELMER, INC.
  • THERMO FISHER SCIENTIFIC INC.
  • ZECOTEK PHOTONICS INC.

図表

目次
Product Code: 6392

KEY FINDINGS

The global biophotonics market is expected to grow at a CAGR of 10.12% for the forecast period of 2019-2027. Because of this, the market value is also anticipated to increase from $ XX million in 2018 and reach $XX million by 2027. The growing elderly population in the world will be significant for driving the market growth, and this particular population is facilitated by the reducing fertility rates amongst the youth and a momentous increase in the life expectancy rate of the aging population that is predicted to grow at a uniform pace in the next ten years.

MARKET INSIGHTS

The global biophotonics market is segmented on the basis of technology, application and end-user. Regardless of such wide market segmentation, it has to face certain restraints due to the prolonging certification & approval procedures and the sluggish commercialization rate. Also, the high price of the biophotonics technology is hindering the Biophotonics market growth. Although, the increasing rate of occurrence of chronic diseases like cancer, diabetes, cardiovascular diseases, respiratory diseases, etc. in the developing countries like India, China, Brazil and Russia will be opening many doors for market development in the global arena. The major factors that are responsible for the increasing frequency of chronic and other diseases in these developing countries are because of the increasing urbanization, smoking, obesity rate and enlarging population.

REGIONAL INSIGHTS

The North American market is backed by the growing investments within the healthcare sector, growing R&D initiatives and the presence of top-class healthcare infrastructure. This is the reason the market dominated the global scene with a share of XX% in the year 2018. The market is predicted to continue its dominance in the coming years due to the rising prevalence of chronic diseases like cancer, Alzheimer disease and diabetes coupled with growing geriatric populace. The Asia-Pacific market will be growing the fastest during the forecast period because of the increasing healthcare expenditure in the region. Countries like India spend over XX% annually of its overall GDP on healthcare. This number is expected to rise to XX% over the forecast period. Also, China's healthcare expenditure is predicted to grow by XX% annually during the forecasted period making it a leader in terms of healthcare spending in the Asia-Pacific.

COMPETITIVE INSIGHTS

The companies that are operating in the global market for biophotonics technology are Zecotek Photonics Inc., Hamamatsu Photonics K.K., Fisba AG, Idex Corp., Medlumics Sl, MKS Instrument, Halma PLC, Thermo Fisher Scientific Inc., Olympus Corporation, Becton, Dickinson, And Company, OpGen, Lumenis Ltd., Perkinelmer, Inc., Oxford Instruments & Carl Zeiss AG.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. IN-VIVO TECHNOLOGY HOLDS THE LARGEST MARKET SHARE IN TERMS OF TECHNOLOGY
    • 3.2.2. ANALYTICS SENSING IS THE FASTEST GROWING APPLICATION
    • 3.2.3. MEDICAL DIAGNOSTICS ARE MAJORLY USED IN TERMS OF END USER

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. INCREASING GERIATRIC POPULATION
    • 4.2.2. DAWN OF NANOTECHNOLOGY
    • 4.2.3. GOVERNMENT INITIATIVES
    • 4.2.4. INCREASING DEMAND FOR POINT OF CARE DEVICES
    • 4.2.5. TECHNICAL ADVANCEMENT
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. HIGH PRICE OF THE BIOPHOTONICS BIOPHOTONIC- BASED INSTRUMENTS
    • 4.3.2. LACK OF PRECISE TRAINING AND KNOWLEDGE FOR USING BIOPHOTONICS TECHNOLOGY
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. GROWING OCCURRENCE OF CHRONIC DISEASES IN DEVELOPING MARKET
    • 4.4.2. WIDE USE OF BIOPHOTONICS IN NON-MEDICAL SECTORS
  • 4.5. MARKET CHALLENGES
    • 4.5.1. ELONGATED CERTIFICATION & APPROVAL PROCEDURE
    • 4.5.2. SLUGGISH COMMERCIALIZATION RATE

5. MARKET BY TECHNOLOGY

  • 5.1. IN-VITRO
  • 5.2. IN-VIVO

6. MARKET BY APPLICATION

  • 6.1. SURFACE IMAGING
  • 6.2. LIGHT THERAPY
  • 6.3. SEE-THROUGH IMAGING
  • 6.4. SPECTRO MOLECULAR
  • 6.5. MICROSCOPY
  • 6.6. BIOSENSORS
  • 6.7. ANALYTICS SENSING
  • 6.8. INSIDE IMAGING (ENDOSCOPY)
  • 6.9. OTHER APPLICATION

7. MARKET BY END USER

  • 7.1. TESTS AND COMPONENTS
  • 7.2. MEDICAL THERAPEUTICS
  • 7.3. MEDICAL DIAGNOSTICS
  • 7.4. NON-MEDICAL APPLICATION

8. KEY ANALYTICS

  • 8.1. PORTER'S FIVE FORCES MODEL
    • 8.1.1. THREAT OF NEW ENTRANTS
    • 8.1.2. THREAT OF SUBSTITUTE PRODUCT
    • 8.1.3. BARGAINING POWER OF BUYERS
    • 8.1.4. BARGAINING POWER OF SUPPLIERS
    • 8.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 8.2. KEY BUYING CRITERIA
    • 8.2.1. TECHNOLOGY
    • 8.2.2. APPLICATION
    • 8.2.3. PRICE
    • 8.2.4. EASE OF ADOPTION
  • 8.3. KEY IMPACTING FACTORS
  • 8.4. OPPORTUNITY MATRIX
  • 8.5. VENDOR LANDSCAPE

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. THE UNITED STATES
    • 9.1.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. THE UNITED KINGDOM
    • 9.2.2. FRANCE
    • 9.2.3. GERMANY
    • 9.2.4. ITALY
    • 9.2.5. SPAIN
    • 9.2.6. REST OF EUROPE
  • 9.3. ASIA PACIFIC
    • 9.3.1. INDIA
    • 9.3.2. CHINA
    • 9.3.3. JAPAN
    • 9.3.4. SOUTH KOREA
    • 9.3.5. AUSTRALIA
    • 9.3.6. REST OF ASIA PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. LATIN AMERICA
    • 9.4.2. MIDDLE EAST AND AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. MARKET SHARE ANALYSIS
  • 10.2. COMPANY PROFILES
    • 10.2.1. BECTON, DICKINSON, AND COMPANY
      • 10.2.1.1. COMPANY OVERVIEW
      • 10.2.1.2. PRODUCT PORTFOLIO
      • 10.2.1.3. SCOT ANALYSIS
      • 10.2.1.4. STRATEGIC INITIATIVES
    • 10.2.2. CARL ZEISS AG
      • 10.2.2.1. COMPANY OVERVIEW
      • 10.2.2.2. PRODUCT PORTFOLIO
      • 10.2.2.3. SCOT ANALYSIS
      • 10.2.2.4. STRATEGIC INITIATIVES
    • 10.2.3. FISBA AG
      • 10.2.3.1. COMPANY OVERVIEW
      • 10.2.3.2. PRODUCT PORTFOLIO
    • 10.2.4. HALMA PLC
      • 10.2.4.1. COMPANY OVERVIEW
      • 10.2.4.2. PRODUCT PORTFOLIO
      • 10.2.4.3. SCOT ANALYSIS
      • 10.2.4.4. STRATEGIC INITIATIVES
    • 10.2.5. HAMAMATSU PHOTONICS K.K.
      • 10.2.5.1. COMPANY OVERVIEW
      • 10.2.5.2. PRODUCT PORTFOLIO
      • 10.2.5.3. SCOT ANALYSIS
      • 10.2.5.4. STRATEGIC INITIATIVES
    • 10.2.6. IDEX CORP.
      • 10.2.6.1. COMPANY OVERVIEW
      • 10.2.6.2. PRODUCT PORTFOLIO
      • 10.2.6.3. SCOT ANALYSIS
    • 10.2.7. LUMENIS LTD.
      • 10.2.7.1. COMPANY OVERVIEW
      • 10.2.7.2. PRODUCT PORTFOLIO
      • 10.2.7.3. SCOT ANALYSIS
      • 10.2.7.4. STRATEGIC INITIATIVES
    • 10.2.8. MEDLUMICS SL
      • 10.2.8.1. COMPANY OVERVIEW
      • 10.2.8.2. PRODUCT PORTFOLIO
    • 10.2.9. MKS INSTRUMENT
      • 10.2.9.1. COMPANY OVERVIEW
      • 10.2.9.2. PRODUCT PORTFOLIO
      • 10.2.9.3. SCOT ANALYSIS
      • 10.2.9.4. STRATEGIC INITIATIVES
    • 10.2.10. OLYMPUS CORPORATION
      • 10.2.10.1. COMPANY OVERVIEW
      • 10.2.10.2. PRODUCT PORTFOLIO
      • 10.2.10.3. SCOT ANALYSIS
      • 10.2.10.4. STRATEGIC INITIATIVES
    • 10.2.11. OPGEN
      • 10.2.11.1. COMPANY OVERVIEW
      • 10.2.11.2. PRODUCT PORTFOLIO
      • 10.2.11.3. SCOT ANALYSIS
      • 10.2.11.4. STRATEGIC INITIATIVES
    • 10.2.12. OXFORD INSTRUMENTS
      • 10.2.12.1. COMPANY OVERVIEW
      • 10.2.12.2. PRODUCT PORTFOLIO
      • 10.2.12.3. SCOT ANALYSIS
      • 10.2.12.4. STRATEGIC INITIATIVES
    • 10.2.13. PERKINELMER, INC.
      • 10.2.13.1. COMPANY OVERVIEW
      • 10.2.13.2. PRODUCT PORTFOLIO
      • 10.2.13.3. SCOT ANALYSIS
      • 10.2.13.4. STRATEGIC INITIATIVES
    • 10.2.14. THERMO FISHER SCIENTIFIC INC.
      • 10.2.14.1. COMPANY OVERVIEW
      • 10.2.14.2. PRODUCT PORTFOLIO
      • 10.2.14.3. SCOT ANALYSIS
      • 10.2.14.4. STRATEGIC INITIATIVES
    • 10.2.15. ZECOTEK PHOTONICS INC.
      • 10.2.15.1. COMPANY OVERVIEW
      • 10.2.15.2. PRODUCT PORTFOLIO
      • 10.2.15.3. SCOT ANALYSIS
      • 10.2.15.4. STRATEGIC INITIATIVE

TABLE LIST

  • TABLE 1 GLOBAL BIOPHOTONICS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 2 GLOBAL BIOPHOTONICS MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
  • TABLE 3 GLOBAL IN-VITRO MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 4 GLOBAL IN-VIVO MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 5 GLOBAL BIOPHOTONICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 6 GLOBAL SURFACE IMAGING MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 7 GLOBAL LIGHT THERAPY MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 8 TYPES OF SEE THROUGH IMAGING SYSTEMS
  • TABLE 9 GLOBAL SEE-THROUGH IMAGING MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 10 GLOBAL SPECTRO MOLECULAR MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 11 TYPES OF MICROSCOPY
  • TABLE 12 GLOBAL MICROSCOPY MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 13 GLOBAL BIOSENSORS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 14 GLOBAL ANALYTICS SENSING MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 15 CAPSULE ENDOSCOPY IN THE MARKET
  • TABLE 16 GLOBAL INSIDE IMAGING (ENDOSCOPY) MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 17 GLOBAL OTHER APPLICATION MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 18 GLOBAL BIOPHOTONICS MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 19 GLOBAL TESTS AND COMPONENTS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 20 GLOBAL MEDICAL THERAPEUTICS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 21 GLOBAL MEDICAL DIAGNOSTICS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 22 GLOBAL NON-MEDICAL APPLICATION MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 23 GLOBAL BIOPHOTONICS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 24 NORTH AMERICA BIOPHOTONICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 25 EUROPE BIOPHOTONICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 26 ASIA PACIFIC BIOPHOTONICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 27 REST OF WORLD BIOPHOTONICS MARKET BY COUNTRY 2019-2027 ($ MILLION)

FIGURES LIST

  • FIGURE 1 GLOBAL BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 GLOBAL BIOPHOTONICS MARKET SHARE BY TECHNOLOGY 2018 & 2027 (%)
  • FIGURE 3 GLOBAL BIOPHOTONICS MARKET BY IN-VITRO 2019-2027 ($ MILLION)
  • FIGURE 4 GLOBAL BIOPHOTONICS MARKET BY IN-VIVO 2019-2027 ($ MILLION)
  • FIGURE 5 GLOBAL BIOPHOTONICS MARKET SHARE BY APPLICATION 2018 & 2027 (%)
  • FIGURE 6 GLOBAL BIOPHOTONICS MARKET BY SURFACE IMAGING 2019-2027 ($ MILLION)
  • FIGURE 7 GLOBAL BIOPHOTONICS MARKET BY LIGHT THERAPY 2019-2027 ($ MILLION)
  • FIGURE 8 GLOBAL BIOPHOTONICS MARKET BY SEE-THROUGH IMAGING 2019-2027 ($ MILLION)
  • FIGURE 9 GLOBAL BIOPHOTONICS MARKET BY SPECTRO MOLECULAR 2019-2027 ($ MILLION)
  • FIGURE 10 GLOBAL BIOPHOTONICS MARKET BY MICROSCOPY 2019-2027 ($ MILLION)
  • FIGURE 11 GLOBAL BIOPHOTONICS MARKET BY BIOSENSORS 2019-2027 ($ MILLION)
  • FIGURE 12 GLOBAL BIOPHOTONICS MARKET BY ANALYTICS SENSING 2019-2027 ($ MILLION)
  • FIGURE 13 GLOBAL BIOPHOTONICS MARKET BY INSIDE IMAGING (ENDOSCOPY) 2019-2027 ($ MILLION)
  • FIGURE 14 GLOBAL BIOPHOTONICS MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
  • FIGURE 15 GLOBAL BIOPHOTONICS MARKET SHARE BY END USER 2018 & 2027 (%)
  • FIGURE 16 GLOBAL BIOPHOTONICS MARKET BY TESTS AND COMPONENTS 2019-2027 ($ MILLION)
  • FIGURE 17 GLOBAL BIOPHOTONICS MARKET BY MEDICAL THERAPEUTICS 2019-2027 ($ MILLION)
  • FIGURE 18 GLOBAL BIOPHOTONICS MARKET BY MEDICAL DIAGNOSTICS 2019-2027 ($ MILLION)
  • FIGURE 19 GLOBAL BIOPHOTONICS MARKET BY NON-MEDICAL APPLICATION 2019-2027 ($ MILLION)
  • FIGURE 20 PORTER'S FIVE FORCES MODEL
  • FIGURE 21 KEY BUYING CRITERIA OF BIOPHOTONICS
  • FIGURE 22 KEY IMPACTING FACTORS OF BIOPHOTONICS
  • FIGURE 23 PREVALENCE OF ALZHEIMER IN THE UNITED STATES FOR 65 AND ABOVE 2016 & 2050 (MILLION)
  • FIGURE 24 THE UNITED STATES BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 25 GROWING GERIATRIC POPULATION IN THE UNITED STATES 2016 & 2060 (MILLION)
  • FIGURE 26 HEALTHCARE EXPENDITURE IN THE UNITED STATES 2016 & 2025 (% OF GDP)
  • FIGURE 27 CANADA BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 28 EUROPEAN GERIATRIC POPULATION OF 60 YEARS AND ABOVE 2000-2050 (MILLION)
  • FIGURE 29 THE UNITED KINGDOM BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 30 FRANCE BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 31 GERMANY BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 32 ITALY BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 33 POPULATION AGED 65 YEARS AND ABOVE IN SPAIN (% OF POPULATION)
  • FIGURE 34 SPAIN BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 35 REST OF EUROPE BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 36 INDIA BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 37 CHINA BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 38 JAPAN BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 39 JAPAN HEALTHCARE EXPENDITURE 2000-2030 ($ MILLION)
  • FIGURE 40 POPULATION AGING MORE THAN OR EQUAL TO 65 IN SOUTH KOREA 2015-2060
  • FIGURE 41 SOUTH KOREA BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 42 AUSTRALIA BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 43 REST OF ASIA PACIFIC BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 44 LATIN AMERICA BIOPHONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 45 GERIATRIC POPULATION IN AFRICA 2015-2050 (MILLION)
  • FIGURE 46 MIDDLE EAST AND AFRICA BIOPHOTONICS MARKET 2019-2027 ($ MILLION)
  • FIGURE 47 MARKET SHARE OF BIOPHOTONICS MARKET 2018 (%)
Back to Top